Omalizumab normalizes the gene expression signature of lesional skin in patients with chronic spontaneous urticaria: A randomized, double‐blind, placebo‐controlled study

Martin Metz; Rebecca Torene; Sergio Kaiser; Michael T. Beste; Petra Staubach; Andrea Bauer; Randolf Brehler; Janine Gericke; Martin Letzkus; Nicole Hartmann; Veit J. Erpenbeck; Marcus Maurer

doi:10.1111/all.13547

Omalizumab normalizes the gene expression signature of lesional skin in patients with chronic spontaneous urticaria: A randomized, double‐blind, placebo‐controlled study

Allergy ◽

10.1111/all.13547 ◽

2018 ◽

Vol 74 (1) ◽

pp. 141-151 ◽

Cited By ~ 7

Author(s):

Martin Metz ◽

Rebecca Torene ◽

Sergio Kaiser ◽

Michael T. Beste ◽

Petra Staubach ◽

...

Keyword(s):

Gene Expression ◽

Gene Expression Signature ◽

Chronic Spontaneous Urticaria ◽

Controlled Study ◽

Double Blind ◽

Double Blind Placebo ◽

Lesional Skin ◽

Expression Signature

Omalizumab normalizes gene expression in lesional skin of patients with chronic spontaneous urticaria: Results from a randomized, double-blind, placebo-controlled study

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2016.02.256 ◽

2016 ◽

Vol 74 (5) ◽

pp. AB64

Keyword(s):

Gene Expression ◽

Chronic Spontaneous Urticaria ◽

Controlled Study ◽

Double Blind ◽

Double Blind Placebo ◽

Lesional Skin

Randomized, double-blind, placebo-controlled study of safety and efficacy of miltefosine in antihistamine-resistant chronic spontaneous urticaria

Journal of the European Academy of Dermatology and Venereology ◽

10.1111/j.1468-3083.2012.04689.x ◽

2012 ◽

Vol 27 (3) ◽

pp. e363-e369 ◽

Cited By ~ 15

Author(s):

M. Magerl ◽

M. Rother ◽

T. Bieber ◽

T. Biedermann ◽

J. Brasch ◽

...

Keyword(s):

Chronic Spontaneous Urticaria ◽

Controlled Study ◽

Double Blind ◽

Safety And Efficacy ◽

Double Blind Placebo

Effects of a topical treatment with spleen tyrosine kinase (SYK) inhibitor in healthy subjects and patients with cold urticaria or chronic spontaneous urticaria: results of a Phase 1a/b randomised double‐blind placebo‐controlled study

British Journal of Clinical Pharmacology ◽

10.1111/bcp.14923 ◽

2021 ◽

Author(s):

Marion C. Dickson ◽

Alexandra Walker ◽

Clive Grattan ◽

Hayley Perry ◽

Nicola Williams ◽

...

Keyword(s):

Tyrosine Kinase ◽

Topical Treatment ◽

Healthy Subjects ◽

Chronic Spontaneous Urticaria ◽

Controlled Study ◽

Spleen Tyrosine Kinase ◽

Cold Urticaria ◽

Double Blind ◽

Double Blind Placebo ◽

Syk Inhibitor

Diamine Oxidase Supplementation in Chronic Spontaneous Urticaria: A Randomized, Double-Blind Placebo-Controlled Study

International Archives of Allergy and Immunology ◽

10.1159/000488142 ◽

2018 ◽

Vol 176 (3-4) ◽

pp. 268-271 ◽

Cited By ~ 7

Author(s):

Mona-Rita Yacoub ◽

Giuseppe A. Ramirez ◽

Alvise Berti ◽

Giuseppe Mercurio ◽

Daniela Breda ◽

...

Keyword(s):

Diamine Oxidase ◽

Chronic Spontaneous Urticaria ◽

Controlled Study ◽

Double Blind ◽

Double Blind Placebo

Faculty Opinions recommendation of Randomized, double-blind, placebo-controlled study of safety and efficacy of miltefosine in antihistamine-resistant chronic spontaneous urticaria.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717953966.793459490 ◽

2012 ◽

Author(s):

Riccardo Asero

Keyword(s):

Chronic Spontaneous Urticaria ◽

Controlled Study ◽

Double Blind ◽

Safety And Efficacy ◽

Double Blind Placebo

Effects of docosahexanoic acid supplementation on inflammatory and subcutaneous adipose tissue gene expression in HIV-infected patients on combination antiretroviral therapy (cART). A sub-study of a randomized, double-blind, placebo-controlled study

Cytokine ◽

10.1016/j.cyto.2018.02.008 ◽

2018 ◽

Vol 105 ◽

pp. 73-79 ◽

Cited By ~ 6

Author(s):

Pere Domingo ◽

José Miguel Gallego-Escuredo ◽

Irene Fernández ◽

Joan Villarroya ◽

Ferran Torres ◽

...

Keyword(s):

Gene Expression ◽

Subcutaneous Adipose Tissue ◽

Controlled Study ◽

Docosahexanoic Acid ◽

Combination Antiretroviral Therapy ◽

Double Blind ◽

Double Blind Placebo ◽

Adipose Tissue Gene Expression ◽

Subcutaneous Adipose ◽

Tissue Gene Expression

Mo1540 THE EFFICACY AND SAFETY OF GCWB104 (FLOS LONICERA EXTRACT) IN FUNCTIONAL DYSPEPSIA: A SINGLE-CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY

Gastroenterology ◽

10.1016/s0016-5085(20)32906-1 ◽

2020 ◽

Vol 158 (6) ◽

pp. S-887-S-888

Author(s):

Nayoung Kim ◽

Yonghoon Choi ◽

Dong Ho Lee

Keyword(s):

Functional Dyspepsia ◽

Controlled Study ◽

Efficacy And Safety ◽

Single Center ◽

Double Blind ◽

Double Blind Placebo

105: The Efficacy of Cernilton® in Patients with Chronic Pelvic Pain Syndrome (CP/CPPS) Type Nih IIIA: A Randomized, Prospective, Double-Blind, Placebo Controlled Study

The Journal of Urology ◽

10.1016/s0022-5347(18)32372-3 ◽

2006 ◽

Vol 175 (4S) ◽

pp. 34-34 ◽

Cited By ~ 3

Author(s):

Henning Schneider ◽

Martin Ludwig ◽

Andreas Horstmann ◽

Jörg Schnitker ◽

Wolfgang Weidner

Keyword(s):

Pelvic Pain ◽

Chronic Pelvic Pain ◽

Chronic Pelvic Pain Syndrome ◽

Pain Syndrome ◽

Controlled Study ◽

Pelvic Pain Syndrome ◽

Double Blind ◽

Double Blind Placebo

884: Phase I, Double-Blind, Placebo-Controlled Study in Healthy Male Subjects to Investigate the Safety, Tolerability, and Pharmacokinetics of DA-8159

The Journal of Urology ◽

10.1016/s0022-5347(18)38133-3 ◽

2004 ◽

Vol 171 (4S) ◽

pp. 234-234 ◽

Cited By ~ 7

Author(s):

Harin Padma-Nathan ◽

Jae Seung Pacik ◽

Byoung Ok Ahn ◽

Kyung Koo Kang ◽

Mi Young Bahng ◽

...

Keyword(s):

Phase I ◽

Controlled Study ◽

Healthy Male ◽

Double Blind ◽

Double Blind Placebo ◽

Male Subjects

480: Intraoperative Port Site Infiltration with Bupivicaine Reduces Post Operative Parenteral Opioid Use in Laparoscopic Urologic Surgery: A Randomized, Double Blind, Placebo Controlled Study

The Journal of Urology ◽

10.1016/s0022-5347(18)37742-5 ◽

2004 ◽

Vol 171 (4S) ◽

pp. 128-128

Author(s):

Herkanwal S. Khaira ◽

J. Stuart Wolf

Keyword(s):

Port Site ◽

Controlled Study ◽

Opioid Use ◽

Double Blind ◽

Double Blind Placebo ◽

Urologic Surgery